Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Florian Naudet, Professeur en thérapeutique, Université de Rennes 1 - Université de Rennes

EXPLAINED: Hallucinogens approved for treating psychiatric disorders what does the science say | Vintage Vibes

A group of international experts has undertaken a critique of the clinical trials conducted to date on the value of hallucinogens in treating psychiatric disorders. Milad Fakurian/Unsplash

Once sidelined in the 1970s, psychedelic substances – ranging from esketamine (a ketamine derivative) and psilocybin (the active ingredient in hallucinogenic mushrooms) to MDMA – are being reintroduced as potential therapies for severe psychiatric disorders.

Psychedelic antidepressants approved

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.